In early experiments, the method's raw single pass error rate was approximately 2 percent for a single target and up to 4 percent for a mixture of 10 targets.
At Inova Women's Hospital, all new parents have the chance to have pharmacogenetic testing for their babies with the results stored in the electronic medical record.
The diagnostics firm recorded $3.2 million in revenues for the quarter and $8.4 million for the year, beating analysts' estimates.
Snyder's new book, "Genomics and Personalized Medicine," serves as a primer for patients and doctors, touching on topics from tailored cancer therapy to wearable devices.
The firm performed a long-term, prospective study and noted that the test improved outcomes for patients and helped doctors monitor patients with benign disease.
In Science this week: Neanderthal-derived DNA linked to modern ailments, and more.
Japan needs to catch up on its gene-editing research efforts, the Japan News writes.
Hundreds of people have signed an online petition calling for zero tolerance to sexual harassment in the sciences.
Jeff Huber, former Google X senior vice president, joins Grail as its CEO.
This webinar will demonstrate how ACMG's recommended variant scoring and classification rules may be applied to standardize reporting on sequencing test results within and across institutions.
This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.
This webinar will discuss Qiagen's approach to address two challenges facing NGS in the clinical research setting: lack of seamless workflow for routine clinical research use and truly relevant content to guide clinical research activities.